You have 9 free searches left this month | for more free features.

pNETs

Showing 1 - 25 of 50

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

Recruiting
  • Multiple Endocrine Neoplasia Type 1
  • Pancreatic Neuroendocrine Tumor
  • EUS-guided fine-needle injection
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Sep 24, 2022

Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning

Recruiting
  • Nonfunctional Pancreatic Neuroendocrine Tumor
  • +2 more
  • EUS-guided ethanol ablation
  • EUS-guided lauromacrogol ablation
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Sep 30, 2022

Tumors, Breast Tumors, Kidney Tumors Trial in Worldwide (alpelisib, everolimus, exemestane)

Completed
  • Neoplasms
  • +3 more
  • Fayetteville, Arkansas
  • +21 more
Dec 4, 2020

Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 Trial in Marseille (Radiofrequency ablation)

Recruiting
  • Neuroendocrine Tumor of Pancreas (Disorder)
  • Neuroendocrine Tumor Grade 1
  • Radiofrequency ablation
  • Marseille, France
    Institut Paoli Calmettes
Jan 5, 2022

Multi-dimensional Fragmentomic Assay for Early Detection of

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Fragmentomic profiles of plasma cfDNA
  • (no location specified)
Apr 27, 2023

Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail

Recruiting
  • Non Functioning Pancreatic Endocrine Tumor
  • Histopathological review, long-term prognosis and quality of life follow-up
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jun 8, 2023

Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

Active, not recruiting
  • Medulloblastoma
  • Neuroectodermal Tumor
  • TTRNA-xALT
  • TTRNA-DCs
  • Los Angeles, California
  • +2 more
Jan 7, 2022

Pancreatic Neuroendocrine Tumour Metastatic Trial in Spain (Sunitinib)

Completed
  • Pancreatic Neuroendocrine Tumour Metastatic
  • Oviedo, Asturias, Spain
  • +8 more
Mar 3, 2020

Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

Active, not recruiting
  • Well Differentiated Pancreatic Endocrine Tumor
  • Everolimus plus Octreotide LAR plus Metformin
  • Milano, Italy
    Fondazione IRCCS Istituto Tumori Milano
Sep 3, 2021

Nonfunctioning Small Neuroendocrine Pancreatic Incidentaloma

Active, not recruiting
  • Neuroendocrine Tumors
    • Louvain, Belgium
    • +21 more
    Oct 8, 2021

    Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

    Recruiting
    • Pancreatic Neuroendocrine Tumor
    • peptide receptor radionuclide therapy with Y-90-DOTATOC
    • Milano, Italy
    • +1 more
    Sep 30, 2022

    Rare Embryonal Tumors of Central Nervous System: International

    Not yet recruiting
    • Embryonal Tumor
      • Yerevan, Armenia
        Hematology Center named after prof. R. Yeolyan
      Jan 25, 2023

      Neuroendocrine Tumors, Tumors, Cancer Trial in Madison (TAS-102, Temozolomide, Filgrastim)

      Active, not recruiting
      • Neuroendocrine Tumors
      • +3 more
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Oct 29, 2021

      Pancreatic Neuroendocrine Tumors in MEN1 Trial (Somatostatin-Analog)

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumors in MEN1
      • (no location specified)
      Apr 5, 2019

      Prognosis Between Pancreatic Neuroendocrine Tumors and

      Completed
      • Neuroendocrine Tumor of Pancreas
      • +2 more
      • No intervention
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital of Zhejiang University School of Medi
      Jul 25, 2021

      Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,

      Completed
      • Medulloblastoma
      • +2 more
      • 3-Dimensional Conformal Radiation Therapy
      • +10 more
      • Los Angeles, California
      • +14 more
      Jan 12, 2022

      Asymptomatic Small Pancreatic Endocrine Neoplasms.

      Recruiting
      • Non Functioning Pancreatic Endocrine Tumor
      • Radiological imaging studies
      • Quality of Life Assessment
      • Milan, Italy
        IRCCS San Raffaele Hospital
      Mar 4, 2022

      Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)

      Completed
      • Metastatic Medulloblastoma
      • +2 more
      • Aurora, Colorado
        Children's Hospital Colorado
      Dec 13, 2021

      Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

      Recruiting
      • Neuroendocrine Tumor of Pancreas
      • Multiple Endocrine Neoplasia Type 1
      • High-dose-high precision MR-guided radiotherapy
      • Utrecht, Netherlands
        UMC Utrecht
      May 29, 2022

      PaCIFiC-CUP Classifies Cancer of Unknown Primary

      Recruiting
      • Unknown Primary Tumors
      • DNA Methylation
        • Guangzhou, Guangdong, China
          Sun Yat-sen university cancer center
        Nov 20, 2023

        Lymph Node Metastases by NF-PanNENs

        Recruiting
        • Non Functioning Pancreatic Endocrine Tumor
          • Milan, Italy
            IRCCS San Raffaele Hospital
          Aug 23, 2022

          Neuroendocrine Tumors Trial in Worldwide (Drug: Everolimus, STZ-5FU)

          Unknown status
          • Neuroendocrine Tumors
          • Aarhus, Denmark
          • +36 more
          Mar 3, 2020

          Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

          Not yet recruiting
          • Metastatic Pancreatic Neuroendocrine Tumor
          • Unresectable Pancreatic Neuroendocrine Carcinoma
          • Lutetium Lu 177 Dotatate
          • +4 more
          • (no location specified)
          Feb 10, 2022